The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Neuroendocrine Neoplasms of the Lung: A Prognostic Spectrum
Open accessAbstract
Purpose: Neuroendocrine (NE) tumors of the lung include typical carcinoid (TC), atypical carcinoid (AC), large-cell NE carcinoma (LCNEC), and small-cell lung carcinoma (SCLC). Their clinicopathologic profiles and relative grade of malignancy have not been defined. Patients and Methods: From 10 Japanese institutes, 383 surgically resected pulmonary NE tumors were collected. The histologic diagnosis was determined by the consensus of a pathology panel consisting of six expert pathologists as TC, AC, LCNEC, or SCLC on the basis of the WHO classification, and its relationship to clinicopathologic profiles was analyzed. Results: Of the 383 tumors, 18 were excluded because of an improper specimen. The pathology panel reviewed the remaining 366 tumors, and a diagnosis of NE tumor was made in 318 patients (87.4%); 55 patients had TC, nine had AC, 141 had LCNEC, and 113 had SCLC. The 5-year survival rates of patients with all stages were as follows: 96.2% for TC, 77.8% for AC, 40.3% for LCNEC, and 35.7% for SCLC. There was significant prognostic difference between TC and AC as well as between AC and LCNEC+SCLC. However, there was no difference between LCNEC and SCLC, and their survival curves were superimposed. The multivariate analysis indicated that histologic type, completeness of resection, symptoms, nodal involvement, and age were significantly prognostic. Conclusion: The grade of malignancy of NE tumors was upgraded in the following order: TC, AC, LCNEC, and SCLC. No prognostic difference was noted between LCNEC and SCLC. The high-grade NE histology uniformly indicated poor prognosis regardless of its histologic type.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PEARSE, A. G. E. (1969) · Journal of Histochemistry & Cytochemistry · doi:10.1177/17.5.303 · Cited by 1,673
Histological Typing of Lung and Pleural Tumours
Travis, W. D., Colby, T. V., Corrin, B., Shimosato, Y., & Brambilla, E. (1999) · Springer eBooks · doi:10.1007/978-3-642-60049-4 · Cited by 1,523
International Union against Cancer
(1959) · Journal of the Faculty of Radiologists · doi:10.1016/s0368-2242(59)80060-9 · Cited by 1,220
Travis, W. D., Linnoila, R. I., Tsokos, M. G., Hitchcock, C. L., Cutler, G. B., Nieman, L., Chrousos, G., Pass, H., & Doppman, J. (1991) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199106000-00003 · Cited by 880
Travis, W. D., Rush, W., Flieder, D. B., Falk, R., Fleming, M. V., Gal, A. A., & Koss, M. N. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199808000-00003 · Cited by 807
Small Cell Lung Carcinoma (SCLC): A Clinicopathologic Study of 100 Cases With Surgical Specimens
Nicholson, S. A., Beasley, M. B., Brambilla, E., Hasleton, P. S., Colby, T. V., Sheppard, M. N., Falk, R., & Travis, W. D. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200209000-00009 · Cited by 395
Large cell neuroendocrine carcinoma of the lung: A clinicopathologic study of eighty-seven cases
Takei, H., Asamura, H., Maeshima, A., Suzuki, K., Kondo, H., Niki, T., Yamada, T., Tsuchiya, R., & Matsuno, Y. (2002) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2002.122523 · Cited by 322
Self-citationNaruke, T., Tsuchiya, R., Kondo, H., & Asamura, H. (2001) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)02609-6 · Cited by 241
Self-citationLung cancer heterogeneity: A blinded and randomized study of 100 consecutive cases
Roggli, V. L., Vollmer, R. T., Greenberg, S. D., McGavran, M. H., Spjut, H. J., & Yesner, R. (1985) · Human Pathology · doi:10.1016/s0046-8177(85)80106-4 · Cited by 234
Jiang, S.-X., Kameya, T., Shoji, M., Dobashi, Y., Shinada, J., & Yoshimura, H. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199805000-00002 · Cited by 210
Self-citation
Cited by
Pavel, M. E., Hainsworth, J. D., Baudin, E., Peeters, M., Hörsch, D., Winkler, R. E., Klimovsky, J., Lebwohl, D., Jehl, V., Wolin, E. M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61742-x · Cited by 1,058
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
Oronsky, B., Ma, P. C., Morgensztern, D., & Carter, C. A. (2017) · Neoplasia · doi:10.1016/j.neo.2017.09.002 · Cited by 763
Travis, W. D. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.08.005 · Cited by 520
Advances in neuroendocrine lung tumors
Travis, W. D. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq380 · Cited by 327
Jann, H., Roll, S., Couvelard, A., Hentic, O., Pavel, M., Müller‐Nordhorn, J., Koch, M., Röcken, C., Rindi, G., Ruszniewski, P., et al. (2011) · Cancer · doi:10.1002/cncr.25855 · Cited by 289
Metadata
- Authors
- Asamura, H., Kameya, T., Matsuno, Y., Noguchi, M., Tada, H., Ishikawa, Y., Yokose, T., Jiang, S.-X., Inoue, T., Nakagawa, K., Tajima, K., & Nagai, K.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-01-01
- Volume
- 24
- Issue
- 1
- Pages
- 70-76
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2107058542
- Cited by
- 468
- References
- 16
- FWCI
- 9.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroendocrine Neoplasms of the Lung: A Prognostic Spectrum. https://app.cochat.ai/papers/10.1200/jco.2005.04.1202
- The paper
- Asamura, H., Kameya, T., Matsuno, Y., Noguchi, M., Tada, H., Ishikawa, Y., Yokose, T., Jiang, S.-X., Inoue, T., Nakagawa, K., Tajima, K., & Nagai, K. (2006). Neuroendocrine Neoplasms of the Lung: A Prognostic Spectrum. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2005.04.1202
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.